Architecture of cannabinoid signaling in mouse retina

Journal of Comparative Neurology

Volumn 518, Issue 18, 2010, Pages 3848-3866

  Hu, Sherry Shu Jung ^a   Arnold, Andy ^a   Hutchens, Jacqueline M ^a   Radicke, Josh ^a   Cravatt, Benjamin F ^b   Wager Miller, Jim ^a   MacKie, Ken ^a   Straiker, Alex ^a  

^a INDIANA UNIVERSITY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

ABHD6; Cannabinoid; CB1; CRIP1a; DGL; FAAH; MGL; NAAA; Retina

Indexed keywords

2 ARACHIDONOYL GLYCEROL; ACYLGLYCEROL LIPASE; ALPHA BETA HYDROLASE DOMAIN 6; AMIDASE; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR INTERACTING PROTEIN 1A; ENDOCANNABINOID; FATTY ACID AMIDASE; GLYCEROL DERIVATIVE; HYDROLASE; LIPOPROTEIN LIPASE; LIPOPROTEIN LIPASE ALPHA; LIPOPROTEIN LIPASE BETA; N ACYLETHANOLAMINE HYDROLYZING ACID AMIDASE; PROTEIN; UNCLASSIFIED DRUG; ABHD6 PROTEIN, MOUSE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AFFECTING AGENT; CARRIER PROTEIN; CRIP1 PROTEIN, MOUSE; FATTY-ACID AMIDE HYDROLASE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 1; HYBRID PROTEIN; ISOENZYME; LIM PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL SUBPOPULATION; DENDRITIC CELL; ENZYME DEGRADATION; ENZYME LOCALIZATION; FEMALE; FUNCTIONAL ANATOMY; MALE; MOUSE; NERVE ENDING; NONHUMAN; PHOTORECEPTOR CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA; RETINA AMACRINE CELL; RETINA BIPOLAR GANGLION CELL; RETINA BLOOD VESSEL; RETINA CONE; RETINA INNER PLEXIFORM LAYER; RETINA ROD; SIGNAL TRANSDUCTION; SYNAPSE; ANATOMY AND HISTOLOGY; ANIMAL; BLOOD VESSEL; C57BL MOUSE; CELL LINE; CYTOLOGY; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

AMIDOHYDROLASES; ANIMALS; BLOOD VESSELS; CARRIER PROTEINS; CELL LINE; ENDOCANNABINOIDS; GLUTAMATE DECARBOXYLASE; HUMANS; ISOENZYMES; LIPOPROTEIN LIPASE; MICE; MICE, INBRED C57BL; MONOACYLGLYCEROL LIPASES; RECEPTORS, CANNABINOID; RECOMBINANT FUSION PROTEINS; RETINA; SIGNAL TRANSDUCTION; CANNABINOID RECEPTOR MODULATORS; LIM DOMAIN PROTEINS;

EID: 77955675828     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.22429     Document Type: Article

References (98)

1. Bacci A, Huguenard JR, Prince DA. 2004. Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431:312-316.
2. + current. J Biol Chem 278:46188-46194.
3. Berghuis P, Rajnicek AM, Morozov YM, Ross RA, Mulder J, Urbán GM, Monory K, Marsicano G, Matteoli M, Canty A, Irving AJ, Katona I, Yanagawa Y, Rakic P, Lutz B, Mackie K, Harkany T. 2007. Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science 315:1212-1216.
4. Bergmann M, Grabs D, Roder J, Rager G, Jeromin A. 2002. Differential expression of neuronal calcium sensor-1 in the developing chick retina. J Comp Neurol 449:231-240. (Pubitemid 34734282)
5. Bisogno T, Delton-Vandenbroucke I, Milone A, Lagarde M, Di Marzo V. 1999. Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. Arch Biochem Biophys 370: 300-307.
6. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, Gangadharan U, Hobbs C, Di Marzo V, Doherty P. 2003. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163:463-468.
7. Blankman JL, Simon GM, Cravatt BF. 2007. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol 14:1347-1356.
8. Bodor AL, Katona I, Nyiri G, Mackie K, Ledent C, Hajos N, Freund TF. 2005. Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci 25:6845-6856.
9. Bracey MH, Hanson MA, Masuda KR, Stevens RC, Cravatt BF. 2002. Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science 298:1793-1796.
10. A) receptor mRNAs in the retina. Cell Mol Neurobiol 11:497-509.
11. 2 receptor messenger RNAs during embryonic development in the rat. Neuroscience 82:1131-1149.
12. Burette AC, Strehler EE, Weinberg RJ. 2009. "Fast" plasma membrane calcium pump PMCA2a concentrates in GABAergic terminals in the adult rat brain. J Comp Neurol 512:500-513.
13. Casini G, Brecha NC, Bosco L, Rickman DW. 2000. Developmental expression of neurokinin-1 and neurokinin-3 receptors in the rat retina. J Comp Neurol 421:275-287.
14. Chang YC, Gottlieb DI. 1988. Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase. J Neurosci 8:2123-2130.
15. Chen J, Matias I, Dinh T, Lu T, Venezia S, Nieves A, Woodward DF, Di Marzo V. 2005. Finding of endocannabinoids in human eye tissues: implications for glaucoma. Biochem Biophys Res Commun 330:1062-1067.
16. Chevaleyre V, Takahashi KA, Castillo PE. 2006. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29:37-76.
17. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. 1996. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384:83-87.
18. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH. 2001. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A 98:9371-9376.
19. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949.
20. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D. 1994. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686-691.
21. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D. 2002. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 99:10819-10824.
22. 1 receptor agonist WIN 55212-2. Vis Neurosci 20:177-188.
23. 1 receptor and dopamine D2 receptor agonists on voltage-gated currents of goldfish cones. Vis Neurosci 21:69-77.
24. 1 and dopamine D1 receptors in ON bipolar cells of goldfish retina. Vis Neurosci 22:55-63.
25. Fukushima T, Ohtsubo T, Tsuda M, Yanagawa Y, Hori Y. 2009. Facilitatory actions of serotonin type 3 receptors on GABAergic inhibitory synaptic transmission in the spinal superficial dorsal horn. J Neurophysiol 102:1459-1471.
26. Gargini C, Terzibasi E, Mazzoni F, Strettoi E. 2007. Retinal organization in the retinal degeneration 10 (rd10) mutant mouse: a morphological and ERG study. J Comp Neurol 500: 222-238.
27. Ghosh KK, Bujan S, Haverkamp S, Feigenspan A, Wassle H. 2004. Types of bipolar cells in the mouse retina. J Comp Neurol 469:70-82.
28. 3H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide. Vis Neurosci 22:693-705.
29. Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, Freund TF. 2004. Segregation of two endocannabinoidhydrolyzing enzymes into pre-and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala.Eur J Neurosci 20:441-458.
30. Guo Y, Wang H, Okamoto Y, Ueda N, Kingsley PJ, Marnett LJ, Schmid HH, Das SK, Dey SK. 2005. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. J Biol Chem 280:23429-23432.
31. Hajos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I, Freund TF. 2000. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 12:3239-3249.
32. Hartveit E. 1997. Functional organization of cone bipolar cells in the rat retina. J Neurophysiol 77:1716-1730.
33. Hashimotodani Y, Ohno-Shosaku T, Kano M. 2007. Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus. J Neurosci 27:1211-1219.
34. Haverkamp S, Wassle H. 2000. Immunocytochemical analysis of the mouse retina. J Comp Neurol 424:1-23.
35. Haverkamp S, Ghosh KK, Hirano AA, Wassle H. 2003. Immunocytochemical description of five bipolar cell types of the mouse retina. J Comp Neurol 455:463-476.
36. Hendrickson A, Troilo D, Djajadi H, Possin D, Springer A. 2009. Expression of synaptic and phototransduction markers during photoreceptor development in the marmoset monkey Callithrix jacchus. J Comp Neurol 512:218-231.
37. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. 1991. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:563-583.
38. Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ. 2004. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47(Suppl 1):345-358.
39. Huang L, Max M, Margolskee RF, Su H, Masland RH, Euler T. 2003. G protein subunit G gamma 13 is coexpressed with G alpha o, G beta 3, and G beta 4 in retinal ON bipolar cells. J Comp Neurol 455:1-10.
40. Jevince AR, Kadison SR, Pittman AJ, Chien CB, Kaprielian Z. 2006. Distribution of EphB receptors and ephrin-β1 in the developing vertebrate spinal cord. J Comp Neurol 497:734-750. (Pubitemid 43993441)
41. Kaneda K, Isa K, Yanagawa Y, Isa T. 2008. Nigral inhibition of GABAergic neurons in mouse superior colliculus. J Neurosci 28:11071-11078.
42. + conductance: a study using glutamate decarboxylase 67-green fluorescent protein knockin mice. Neuroscience 157:781-797.
43. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M. 2009. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89:309-380.
44. Katona I, Urban GM, Wallace M, Ledent C, Jung KM, Piomelli D, Mackie K, Freund TF. 2006. Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26:5628-5637.
45. Kim J, Alger BE. 2004. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci 7:697-698.
46. Koulen P, Fletcher EL, Craven SE, Bredt DS, Wassle H. 1998. Immunocytochemical localization of the postsynaptic density protein PSD-95 in the mammalian retina. J Neurosci 18:10136-10149. (Pubitemid 28543787)
47. Kozak KR, Rowlinson SW, Marnett LJ. 2000. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J Biol Chem 275: 33744-33749.
48. Kreitzer AC, Regehr WG. 2001. Cerebellar depolarizationinduced suppression of inhibition is mediated by endogenous cannabinoids. J Neurosci 21:RC174.
49. Kreitzer AC, Carter AG, Regehr WG. 2002. Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum. Neuron 34:787-796.
50. Lalonde MR, Jollimore CA, Stevens K, Barnes S, Kelly ME. 2006. Cannabinoid receptor-mediated inhibition of calcium signaling in rat retinal ganglion cells. Mol Vis 12:1160-1166.
51. Leung D, Saghatelian A, Simon GM, Cravatt BF. 2006. Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry 45:4720-4726.
52. Maione S, Cristino L, Migliozzi AL, Georgiou AL, Starowicz K, Salt TE, Di Marzo V. 2009. TRPV1 channels control synaptic plasticity in the developing superior colliculus. J Physiol 587:2521-2535.
53. Matias I, Wang JW, Moriello AS, Nieves A, Woodward DF, Di Marzo V. 2006. Changes in endocannabinoid andpalmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. Prostaglandins Leukot Essent Fatty Acids 75: 413-418.
54. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564.
55. Matsuda S, Kanemitsu N, Nakamura A, Mimura Y, Ueda N, Kurahashi Y, Yamamoto S. 1997. Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues. Exp Eye Res 64:707-711.
56. Matyas F, Urban GM, Watanabe M, Mackie K, Zimmer A, Freund TF, Katona I. 2008. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology 54:95-107.
57. May CA, Nakamura K, Fujiyama F, Yanagawa Y. 2008. Quantification and characterization of GABA-ergic amacrine cells in the retina of GAD67-GFP knock-in mice. Acta Ophthalmol 86:395-400.
58. McKinney MK, Cravatt BF. 2005. Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74:411-432.
59. Milam AH, Dacey DM, Dizhoor AM. 1993. Recoverin immunoreactivity in mammalian cone bipolar cells. Vis Neurosci 10:1-12.
60. Munro S, Thomas KL, Abu-Shaar M. 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65.
61. Negishi K, Kato S, Teranishi T. 1988. Dopamine cells and rod bipolar cells contain protein kinase C-like immunoreactivity in some vertebrate retinas. Neurosci Lett 94:247-252.
62. 1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a. Mol Pharmacol 72:1557-1566.
63. Okabe S, Shiomura Y, Hirokawa N. 1989. Immunocytochemical localization of microtubule-associated proteins 1A and 2 in the rat retina. Brain Res 483:335-346.
64. Okamoto Y, Morishita J, Tsuboi K, Tonai T, Ueda N. 2004. Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 279:5298-5305.
65. Patricelli MP, Lashuel HA, Giang DK, Kelly JW, Cravatt BF. 1998. Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization. Biochemistry 37:15177-15187.
66. Pignatelli V, Strettoi E. 2004. Bipolar cells of the mouse retina: a gene gun, morphological study. J Comp Neurol 476:254-266.
67. 1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana. Brain Res Mol Brain Res 58:240-245.
68. Porcella A, Maxia C, Gessa GL, Pani L. 2000. The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein. Eur J Neurosci 12:1123-1127.
69. Qin N, Neeper MP, Liu Y, Hutchinson TL, Lubin ML, Flores CM. 2008. TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. J Neurosci 28:6231-6238.
70. Rabie A, Thomasset M, Parkes CO, Clavel MC. 1985. Immunocytochemical detection of 28 000-MW calcium-binding protein in horizontal cells of the rat retina. Cell Tissue Res 240:493-496.
71. Randall MD, Kendall DA. 1997. Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur J Pharmacol 335:205-209.
72. Randall MD, Kendall DA. 1998a. Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery. Eur J Pharmacol 346: 51-53.
73. Randall MD, Kendall DA. 1998b. Endocannabinoids: a new class of vasoactive substances. Trends Pharmacol Sci 19: 55-58.
74. Randall MD, Alexander SP, Bennett T, Boyd EA, Fry JR, Gardiner SM, Kemp PA, McCulloch AI, Kendall DA. 1996. An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun 229:114-120.
75. Rohrenbeck J, Wassle H, Heizmann CW. 1987. Immunocytochemical labelling of horizontal cells in mammalian retina using antibodies against calcium-binding proteins. Neurosci Lett 77:255-260.
76. Schlicker E, Timm J, Gothert M. 1996. Cannabinoid receptormediated inhibition of dopamine release in the retina. Naunyn Schmiedebergs Arch Pharmacol 354:791-795.
77. Schreiner DS, Jande SS, Lawson DE. 1985. Target cells of vitamin D in the vertebrate retina. Acta Anat 121: 153-162.
78. Shen M, Thayer SA. 1998. The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons. Brain Res 783:77-84.
79. Shiells R, Falk G. 1992. Retinal on-bipolar cells contain a nitric oxide-sensitive guanylate cyclase. Neuroreport 3: 845-848.
80. Simon GM, Cravatt BF. 2006. Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J Biol Chem 281:26465-26472.
81. Sjostrom PJ, Turrigiano GG, Nelson SB. 2003. Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors. Neuron 39:641-654.
82. Solorzano C, Zhu C, Battista N, Astarita G, Lodola A, Rivara S, Mor M, Russo R, Maccarrone M, Antonietti F, Duranti A, Tontini A, Cuzzocrea S, Tarzia G, Piomelli D. 2009. Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. Proc Natl Acad Sci U S A 106:20966-20971.
83. Stella N, Schweitzer P, Piomelli D. 1997. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773-778.
84. Straiker A, Mackie K. 2009. Cannabinoid signaling in inhibitory autaptic hippocampal neurons. Neuroscience (in press).
85. Straiker A, Sullivan JM. 2003. Cannabinoid receptor activation differentially modulates ion channels in photoreceptors of the tiger salamander. J Neurophysiol 89:2647-2654.
86. 1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system. Proc Natl Acad Sci USA 96:14565-14570.
87. 1 receptors in the human anterior eye and retina. Invest Ophthalmol Vis Sci 40: 2442-2448.
88. Straiker A, Hu SS, Long J, Arnold A, Wager-Miller J, Cravatt BF, Mackie K. 2009. Monoacyl glycerol lipase (MGL) limits the duration of endocannabinoid-mediated depolarizationinduced suppression of excitation (DSE) in autaptic hippocampal neurons. Mol Pharmacol (in press).
89. Struik ML, Yazulla S, Kamermans M. 2006. Cannabinoid agonist WIN 55212-2 speeds up the cone response to light offset in goldfish retina. Vis Neurosci 23:285-293.
90. Tamamaki N, Yanagawa Y, Tomioka R, Miyazaki J, Obata K, Kaneko T. 2003. Green fluorescent protein expression andcolocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J Comp Neurol 467:60-79.
91. Tsuboi K, Sun YX, Okamoto Y, Araki N, Tonai T, Ueda N. 2005. Molecular characterization of N-acylethanolaminehydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J Biol Chem 280: 11082-11092.
92. Wahlin KJ, Moreira EF, Huang H, Yu N, Adler R. 2008. Molecular dynamics of photoreceptor synapse formation in the developing chick retina. J Comp Neurol 506: 822-837.
93. Warrier A, Wilson M. 2007. Endocannabinoid signaling regulates spontaneous transmitter release from embryonic retinal amacrine cells. Vis Neurosci 24:25-35.
94. Wassle H, Puller C, Muller F, Haverkamp S. 2009. Cone contacts, mosaics, and territories of bipolar cells in the mouse retina. J Neurosci 29:106-117.
95. Wilson RI, Nicoll RA. 2001. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410:588-592.
96. Yazulla S. 2008. Endocannabinoids in the retina: from marijuana to neuroprotection. Prog Ret Eye Res 27:501-526.
97. Yazulla S, Studholme KM, McIntosh HH, Deutsch DG. 1999. Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina. J Comp Neurol 415:80-90.
98. Yazulla S, Studholme KM, McIntosh HH, Fan SF. 2000. Cannabinoid receptors on goldfish retinal bipolar cells: electronmicroscope immunocytochemistry and whole-cell recordings. Vis Neurosci 17:391-401.